Summary We sought to determine whether women with in situ or invasive squamous cell vulvar cancer were more likely than other women to have had a previous or concurrent tumour at other anogenital sites. One hundred and fifty-eight women with vulvar cancer were identified who were first diagnosed during 1980-1985, were ages 18-79 years at that time, and were residents of one of three counties in western Washington. Two control groups were selected: (1) from records of hospital pathology departments, a sample of 113 women with certain benign conditions of the vulva; (2) through random digit dialing, a sample of 212 women from the general population of these counties. Information on a history of other cancers, and on sexual, reproductive, medical, and demographic characteristics was collected from cases and controls in at-home interviews. Cases were more likely to report a history of other anogenital cancers than were controls, with relative risks of 3.5-29.8, depending on the type of case group and type of control. These associations were not explained by case-control differences in demographic characteristics or frequency of cervical screening. On the other hand, prior or concurrent non-anogenital cancers were equally common in cases and controls. These results support the hypothesis that the different anogenital cancers have at least one aetiology in common.
Recent research suggests that cancers of the cervix, vulva, and anus may share one or more risk factors (Peters et al., 1984; Okagaki, 1984) . If this is true, women with cancer at one anogenital site would be at increased risk of developing another anogenital tumour. One way to examine this possibility is to see if women with cancer at a specific anogenital site were more likely than other women to have had a previous or concurrent tumour at another anogenital site.
There have been numerous reports of women with squamous cell cancer of the vulva who have had one or more second primary malignancies of the anogenital tract (Taussig, 1940; Cromer, 1963; Day, 1958; Caberra et al., 1966) , especially the cervix (Franklin & Rutledge, 1974; Friedrich et al., 1980) , that were detected before (McPherson et al., 1963) , simultaneous with (Eichner, 1956 ), or after the vulvar tumour (Diehl et al., 1951) . While these reports are intriguing, they were not derived from a defined population, nor were the cases compared to a control group. Using data on cancer incidence rates from the Connecticut Tumor Registry, Schoenberg (1977) showed that women who had cervical cancer were at greater risk for other anogenital malignancies compared with other women. In a hospitalbased, case-control study of vulvar cancer, Mabuchi et al. (1985) found that six of 149 women with vulvar cancer but none of 149 controls had a history of prior urogenital cancer.
As part of a case-control study of women with in situ and invasive vulvar cancer, we had the opportunity to examine the hypothesis that multiple anogenital malignancies occur more commonly that would be predicted by chance.
Patients and methods
With the assistance of the population-based cancer reporting system in western Washington, we identified all women ages 18-79 years with in situ or invasive vulvar cancer who were residents of King, Pierce, or Snohomish Counties and were diagnosed during [1980] [1981] [1982] [1983] [1984] [1985] (Table   III) . Strong associations were present when prior and concurrent tumours were examined separately (Table III) .
Among the 19 women who were diagnosed with in situ vulvar cancer who reported a prior anogenital tumour, an average of 12 years elapsed between the diagnosis of the anogenital and the vulvar tumours. Only 16% of these women reported an interval of less than 5 years between the two diagnoses, and 42% of the women reported an interval of more than 10 years between tumours. All four women who were diagnosed with invasive vulvar cancer and who reported a prior anogenital tumour reported an interval of more than 10 years between tumours. The majority (81%) of these non-vulvar anogenital cancers were cervical tumours, but there were also five anal and two vaginal cancers reported.
These associations were not explained by case-control differences in demographic characteristics. Adjusting separately for education, income, reference year, and county of residence altered the odds ratio only slightly. Because only five biopsy controls and two RDD controls reported a history of anogenital cancer, adjusting simultaneously for all demographic differences between cases and controls was not feasible.
The association between vulvar cancer and prior anogenital tumours did not appear to be a consequence of radiation treatment of the initial anogenital tumour. Only four women reported treatment of their initial tumour by radiation, and the magnitude of the association was unaffected by the exclusion of these women. majority of the other cancers were of the breast (N = 13), skin (N = I 1), endometrium (N = 5), and colon (N = 2).
Discussion
We found that women with in situ or invasive vulvar cancer reported a history of prior or concurrent anogenital tumours far more often than did women in either control group. This association is likely to be confined to squamous cell tumours. Of the 16 women with non-squamous cell vulvar tumours (these diagnoses included melanoma, basal cell cancer, and Paget's disease), none reported a prior or concurrent anogenital malignancy. As noted earlier, cases and controls did not differ substantially in their accuracy of reporting a history of prior or concurrent anogenital cancer; thus, recall bias could not have explained the higher proportion of anogenital cancers among the cases. Nor were differences in the frequency of cervical screening among cases and controls responsible for the positive association of anogenital cancers with vulvar cancer, because the association remained after adjustment for differences in screening history.
We believe that the most reasonable interpretation of these observations is that the association is real. However, our results do not allow us to discriminate between several possibilities regarding its basis. One possibility is that the association between vulvar cancer and a history of prior or concurrent anogenital cancer reflects a common aetiology, which is likely to be a sexually transmitted disease. Or, it could be that these tumours are caused by different sexually transmitted diseases, several of which often occur in the same individual. Indeed, it is well known that people infected with one sexually transmitted organism are more likely to be at risk for other sexually transmitted infections. And, evidence of exposure to many sexually transmitted organisms has been observed in women with cervical cancer, including syphilis, genital herpes, human papilloma virus, and Chlamydia (Levin et al., 1942; Rojel, 1952; Melnick et al., 1974; Kauffman & Adam, 1986; Durst et al., 1983; Syrjanen et al., 1985; Schachter et al., 1982; Cardillo, 1985) . These same diseases also have been found more often in women with vulvar cancer than would be expected in a similar group of women without this disease (Franklin & Rutledge, 1974; Mabuchi et al., 1985; Schwartz & Naftolin, 1981; Rueda-Leverone et al., 1987) and have been found in patients with anal cancer more often than in controls (Gal et al., 1987; Bogomoletz et al., 1985; Daling et al., 1987) .
Recently, there has accumulated strong evidence to suggest that human papilloma virus is one aetiology common to all anogenital cancers. Human papilloma virus has been found in tumour tissue from the cervix, vulva, vagina, and anus (Okagaki, 1984; Durst et al., 1983; Syrjanen et al., 1985; Rueda-Leverone et al., 1987; Gal et al., 1987; Winkler & Richart, 1987) . In addition, there have been several reports of multicentric human papilloma virus infections in the same individual (Sfameni et al., 1986; Walker et al., 1983; Bergeron et al., 1987) . Finally, there have been several reports of finding the same type of human papilloma virus in multiple anogenital cancers in the same individual (Weed et al., 1983; McCance et al., 1985; Beckmann et al., 1988) . Genital herpes and smoking are two additional putative risk factors that are found more often among cases with cervical (Clarke et al., 1982; Brinton et al., 1986) , anal (Daling et al., 1987) , and vulvar (Schwartz & Naftolin, 1981; Newcomb et al., 1984) cancer than among controls. Whether herpes simplex virus type 2, human papilloma virus, and smoking are independent risk factors or whether they interact with each other in the development of anogenital cancers remains to be clarified.
